Comment on Valenciano et al's "Unsafe injecting practices among attendees of syringe exchange programmes in France".
Des Jarlais
D C
DC
D002047:Buprenorphine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D018671:Needle-Exchange Programs; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy*
D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine